MTEMQ
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for th… Read more
Market Cap & Net Worth: MTEMQ (MTEMQ)
MTEMQ (NASDAQ:MTEMQ) has a market capitalization of $0.94 ($0.94) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #51251 globally and #15937 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MTEMQ's stock price $0.00 by its total outstanding shares 9373 (9.37K).
MTEMQ Market Cap History: 2025 to 2025
MTEMQ's market capitalization history from 2025 to 2025. Data shows growth from $0.94 to $0.94 (0.00% CAGR).
MTEMQ Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MTEMQ's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MTEMQ by Market Capitalization
Companies near MTEMQ in the global market cap rankings as of March 18, 2026.
Key companies related to MTEMQ by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
MTEMQ Historical Marketcap From 2025 to 2025
Between 2025 and today, MTEMQ's market cap moved from $0.94 to $ 0.94, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $0.94 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MTEMQ was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $0.94 USD |
| MoneyControl | $0.94 USD |
| MarketWatch | $0.94 USD |
| marketcap.company | $0.94 USD |
| Reuters | $0.94 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.